Alterations in ApoB‐carrying VLDL, triglycerides, and inflammation markers link adiposity to a predisposition to atherogenic plaques, atherothrombotic CVD [27, 28], and coronary artery disease [29], yet potential mechanisms underlying the associations between unfavorable lipid profiles and kidney, respiratory, or neoplastic diseases are not fully understood. Here, APOB is linked to coronary artery disorder.